Predicting speed of cognitive decline in early Alzheimer’s

The variability in the progression of cognitive decline among individuals diagnosed with early Alzheimer’s disease has posed significant challenges for patients, caregivers, and clinicians alike. Now a recent study published in Neurology explores the potential of predictive models to provide clearer prognostic information. Conducted by a team at the Amsterdam University Medical Center, Netherlands, the study also assesses how recently approved Alzheimer’s drugs might slow cognitive decline.